Health Reform – Getting every medical treatment possible isn’t always a good thing

As we move into a post- health reform environment, the first priority is implementing the reform provisions that reduce the number of uninsured. The second, and much harder priority, is to improve care while reducing costs. Why is this so much harder? One reason is that many members of the public, patient advocates, and providers have a firm belief that all medical treatment available – either drugs or medical procedures – for a particular condition should be used until that condition is cured. Even if a particular treatment has just a small chance (or maybe not much chance at all) of working, it’s still worth trying because it might just work for that one person.

The problem with this belief is it ignores the fact that medical treatment can and does often have serious unintended consequences or side effects. Some treatments may not work to treat illness and otherwise be benign. Others may be effective, but have such debilitating side effects that are either known or unknown that the cure is worse than the disease. The additional problem is that medical care has become so specialized and high pressure – especially for those primary care doctors who we somehow expect to see 35 or more patients a day – that it’s hard even for the most dedicated physicians to keep up with even all the independent research on available drugs and treatments.

As a result we have situations like Sarah Avery reports about today in the News and Observer. Avery has a story about serious side effects from a drug called metoclopramide. Metoclopramide has been in use for over thirty years to treat severe nausea, primarily in chemotherapy patients and for people with diabetes also suffering from nausea. Like many drugs however, drug company marketing and related activity along with the general trend toward more use of medical treatment for everyone has resulted in much wider and longer-term use of the drug.

Unfortunately, as Avery reports today, it turns out that use of metoclopramide causes the majority of cases in the US of tardive dyskinesia, or lifelong involuntary tics and movements that can be severe and debilitating. The risk is higher for people who use the drug longer than 12 weeks or use high doses of the drug. Indeed, the dangers of long-term use of metoclopramide have been reported in the national media as much as a year ago already, making it all the more amazing that this drug would still be prescribed for long-term use or in any case but the limited ones where the benefits of the drug truly outweigh the serious risks.

Health reform gives us the opportunity to address the issue that Avery writes about today. Providing more information and studies about drugs like metoclopramide can help physicians make the tough decisions when to provide a drug like this. Better electronic medical record systems combined with better coordination of care can also provide an early warning system to identify patients who might be harmed by inappropriate prescribing of drugs like metoclopramide and recommend more appropriate treatments. Not only does this improve care, but it also saves money, and that’s one side effect that should be welcomed by everyone.



  1. […] This post was mentioned on Twitter by Brian Hunt, BIMedicalNews. BIMedicalNews said: Health Reform – Getting every medical treatment possible isn't always a good thing – The Progressive Pulse (blog) http://bit.ly/asKgwy […]

  2. K Murphy

    May 27, 2010 at 1:43 pm

    Ed Blizzard, a Houston attorney, who was also quoted in Sarah Avery’s piece, has a similar story on Huffington Post. He raised concerns that Health Care Reform will make these dangerous drugs even more accessible to the public. While he lauds the overall goals, he is worried by the current regulatory mechanisms meant to protect patients and the public.

    You can see his story here: http://www.huffingtonpost.com/edward-f-blizzard/the-generic-problem-with_b_537605.html

    His firm also has a website with more information on Reglan, metoclopramide and tardive dyskinesia that you can find here: http://www.ReglanJustice.com/

  3. Alex

    June 2, 2010 at 6:17 pm

    Fantastic article Adam!
    I have to take so many pharmaceuticals and I never take them lightly.

    I was on an MS drug and the company told me it was impossible I was having certain side effects. When I went off the drug the side effects went away in days. The drug companies have these organizations which help you when you go on these expensive MS drugs. I feel they have two purposes one is to keep you happy and on their drug and second to find out before the FDA if you are having a problem.

    As consumers we need to read all the warnings and if we have a problem bring it to our Doctors attention right away.

    We also need to question the Doctor why we are on a Drug. I was given a drug by my PCP and it just did not make sense to me I did my own research and found the drug not only showed no promise off label in trials but could cause permanent damage.
    I never started taking it.

Check Also

Senator Richard Burr: Makes up his own facts about NC Medicaid in order to criticize it

North Carolina’s Senator Burr used to be a ...

Top Stories from NCPW

  • News
  • Commentary

It’s still not clear exactly how much damage Hurricane Florence left in her wake, but "the show [...]

When the Silent Sam Confederate Statue was toppled at UNC-Chapel Hill last month, a flurry of text m [...]

Having devastated the southeast coast of North Carolina, Hurricane Florence is now a tropical depres [...]

The U.S. Commission on Civil Rights has finally released its report and recommendations on minority [...]

To this point, everything about Brett Kavanaugh -- from his indoctrination in  Kenneth Starr's [...]

On June 6, 1944, the day of the great Allied Forces D-Day invasion of France, many historians agree [...]

On Sunday, Governor Roy Cooper declared that affordable housing would be a key focus in the recovery [...]

The post A disastrous idea for storm-ravaged North Carolina appeared first on NC Policy Watch. [...]